Fagron
Fagron is a Netherlands-based multinational company that manufactures and supplies compound pharmaceuticals for hospitals, pharmacies, clinics and patients.
Business Model:
Revenue: $665.3M
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Fagron Information
Geographic Data
Address: Venkelbaan 101
City: Capelle aan den IJssel
State: zuid-holland
Zip: 2908 KE
Country: NL
Financial Info
Stage:
post ipo equity
Raised Last:
$239M
Raised Total:$152M
Social
Metrics
576,932Website Global Rank
77,451Website Monthly Traffic
Twitter Followers
Description
Fagron is a Netherlands-based multinational company that manufactures and supplies compound pharmaceuticals for hospitals, pharmacies, clinics and patients.
Contact Phone:
Contact Email:
Fagron went public on 10/12/2007 on the Other
Listed Exchange:
Other
IPO Date:
10/12/2007
Ticker Symbol:
FAGR
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2016 | Post-IPO Equity | 2 | $239.1M |
Waterland Private Equity Marc Coucke Waterland Private Equity Marc Coucke |
2/2022 | Post-IPO Debt | $151.9M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 2/2022 | Letco | |
| 5/2019 | Central de Drogas | |
| 4/2018 | HUMCO | |
| 10/2017 | All Chemistry | |
| 8/2017 | Kemig | |
| 5/2015 | AnazaoHealth Corporation | |
| 4/2013 | Freedom Pharmaceuticals | |
| 11/2012 | ApodanNordic PharmaPackaging | |
| 11/2012 | Orbus Pharma | |
| 11/2012 | Florien |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
